Expression of all known vasopressin receptor subtypes by small cell tumors implies a multifaceted role for this neuropeptide

Cancer Research

Volumn 58, Issue 9, 1998, Pages 1866-1871

  North, William G ^a   Fay, Michael J ^a,b   Longo, Kenneth A ^a   Du, Jinlin ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b MIDWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROPEPTIDE; PHOSPHOLIPASE A2; PHOSPHOLIPASE C; PHOSPHOLIPASE D; PROTEIN KINASE C; VASOPRESSIN RECEPTOR; VASOPRESSIN V1 RECEPTOR; VASOPRESSIN V2 RECEPTOR;

ARTICLE; CANCER CELL CULTURE; DISEASE CLASSIFICATION; DNA SEQUENCE; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; LUNG SMALL CELL CANCER; MESSENGER RNA SYNTHESIS; PRIORITY JOURNAL; TUMOR DIFFERENTIATION;

ANIMALS; BASE SEQUENCE; BLOTTING, NORTHERN; BLOTTING, WESTERN; CARCINOMA, SMALL CELL; DNA PRIMERS; HUMANS; LUNG NEOPLASMS; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; RABBITS; RECEPTORS, VASOPRESSIN; RNA, MESSENGER; TUMOR CELLS, CULTURED; VASOPRESSINS;

EID: 0032080379     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. North, W. G., Biosynthesis of vasopressin and neurophysins. In: D. M. Gash and G. J. Boer (eds.), Vasopressin: Principles and Properties, pp. 175-209. New York: Plenum Press, 1987.
2. Carmichael, M. C., and Kumer, R. Molecular biology of vasopressin receptors. Semin. Nephrol. 14: 341-348, 1994.
3. 2 lysine vasopressin receptor and oxytocin receptor from pig LLC-PK1 cells: two new members of the vasopressin-oxytocin receptor family. In: P. Gross, D. Richter, and G. I. Robertson (eds.), Vasopressin, pp. 45-57. Paris: John Libbey Eurotext, 1993.
4. Burnatowska-Hledin, M. A., Spielman, W. S., Smith, W. L., Shi, P., Meyer, J. M., and Dewitt, D. L. Expression cloning of an AVP-activated, calcium-mobilizing receptor from rabbit kidney medulla. Am. J. Physiol., 268: F1198-F1210, 1995.
5. Friedmann, A. S., Malott, K. A., Memoli, V. A., Pai, S. I., Yu, X., and North W. G. Products of vasopressin gene expression in small-cell carcinoma of the lung. Br. J. Cancer, 69: 260-263, 1994.
6. Woll, P. J., and Rozengurt, E. Neuropeptides as growth regulators. Br. Med. Bull., 45: 492-505, 1989.
7. 1 vasopressin receptors are present in both variant and classical forms of small-cell tumor cells. Peptides, 18: 985-993, 1997.
8. Longo, K. A., Fay, M. J., and North, W. G. Evidence for the expression of a novel vasopressin-activated calcium mobilizing receptor (VACM-1) in human breast cancer and lung cancer. Mol. Biol. Cell, 7: 3761, 1996.
9. 1a-receptors in variant SCCL. Cancer Lett., 82: 167-174, 1994.
10. Badley, J. E. A simple, rapid method for the purification of Poly A+ RNA. BioTechniques, 6: 114-116, 1988.
11. North, W. G., and Yu, X. Vasopressin mRNA and neurophysin-related cell-surface antigen (NRSA) in small-cell carcinoma. Peptides, 14: 303-307, 1993.
12. North, W. G., LaRochelle, F. T., Hajdar, J., Sawyer, W. H., and Valtin, H. Characterization of an antiserum used in a radioimmunoassay for arginine-vasopressin: implications for reference standards. Endocrinology, 103: 1976-1984, 1978.
13. North, W. G. Neuropeptide production by small cell carcinoma: vasopressin and oxytocin as plasma markers of disease. J. Clin. Endocrinol. Metab., 73: 1316-1320, 1991.
14. Laemmli, U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (Lond.), 227: 680-685, 1970.
15. 1a vasopressin receptor. J. Biol. Chem., 269: 3304-3310, 1994.
16. Hirasawa A., Shibata, K., Kotosai, K., and Tsujimoto, G. Cloning, functional expression and tissue distribution of human cDNA for the vascular-type vasopressin receptor. Biochem. Biophys. Res. Commun., 203: 72-79, 1994.
17. 1b vasopressin receptor. J. Biol. Chem., 269: 27088-27092, 1994.
18. de Keyzer, Y., Auzan, C., Lenne, F., Beldjord, C. Thibonnier, M., Bertagna, X., and Clauser, E. Cloning and characterization of the human V3 pituitary vasopressin receptor. FEBS Lett., 356: 215-220, 1994.
19. Birnbaumer, M., Siebold, A., Rosenthal, W., and Bichet, D. G. The human ADH receptor: the gene, the cDNA, the protein. In: P. Gross, D. Richter, and G. I. Robertson (eds.), Vasopressin, pp. 19-31. Paris: John Libbey Eurotext, 1993.
20. 2 receptor mRNA in human lung. Peptides. 17: 477-481, 1996.
21. Brambilla, E., Moro, D., Gazzeri, S., Brichon, P. Y., Nagy-Mignotte, H., Morel, F., Jacrot, M., and Brambilla, C. Cytotoxic chemotherapy induces cell differentiation in small-cell lung carcinoma. J. Clin. Oncol., 9: 50-61, 1991.
22. Carney, D. N., Gazdar, A. F., Bepler, G., Guccion, J. G., Marangos, P. J., Moody, T. W-., Zweig, M. H., and Minna, J. D. Establishment and identification of small cell lung cancer cells lines having classic and variant features. Cancer Res., 45: 2913-2923, 1985.
23. 2-vasopressin receptor from bovine kidney. In: P. Gross, D. Richter, and G. L. Robertson (eds.), Vasopressin, p; 582. Paris: John Libbey Eurotext, 1993.
24. Sadeghi, H. M., Innamorati, G., and Birnbaumer, M. An X-linked NDI mutation reveals a requirement for cell surface V2R expression. Mol. Endocrinol., 11: 706-713, 1997.
25. Brownstein, M. J., and Lolait, S. J. Hereditary nephrogenic diabetes insipidus. In: P. Gross, D. Richter, and G. I. Robertson (eds.), Vasopressin, pp. 33-43. Paris: John Libbey Eurotext, 1993.
26. Wimalawansa, S. J. Purification and biochemical characterization of neuropeptide Y2 receptor. Am. Soc. Biochem. Mol. Biol., 270: 18523-18530, 1995.
27. 1-vascular vasopressin receptors. Regul. Pept., 45: 79-84, 1993.
28. Bilezikjian, L. M., Blound, A.I., and Vale, W. W. The cellular actions of vasopressin on corticotrophs of the anterior pituitary: resistance to glucocorticoid action. Mol. Endocrinol., 1: 451-458, 1987.
29. Zachary, I., Sinnett-Smith, J., and Rozengurt, E. Stimulation of tyrosine kinase activity after addition of bombesin, vasopressin, and endothelin to intact cells. J. Biol. Chem., 266: 24126-24133, 1991.
30. Zachary, I., Sinnett-Smith, J., and Rozengurt, E. Bombesin, vasopressin, and endothelin stimulation of tyrosine phosphorylation in Swiss 3T3 cells. J. Biol. Chem., 267: 19031-19034, 1992.
31. Zachary, I., Sinnett-Smith, J., Turner, C. E., and Rozengurt, E. Bombesin, vasopressin, and endothlin rapidly stimulates tyrosine phosphorylation of focal adhesion-associated protein paxillin in Swiss 3T3 cells. J. Biol. Chem., 268: 22060-22065, 1993.
32. 2 receptor in Xenopus laevis oocytes by porcine kidney cell line (LLC-PK) messenger RNA. Biochem. Biophys. Res. Commun., 174: 149-155, 1990.
33. Taylor, A. H., Ang, V. T. Y., Jenkins, J. S., Silverlight, J. J., Coombes, R. C., and Lauqmani, Y. A. Interaction of vasopressin and oxytocin with human breast cancer cells. Cancer Res., 50: 7882-7886, 1990.
34. Kaur, G., Viallet, J., Laborda, J., Blair, O., Gazdar, A. F., Minna, J. D., and Sausville, E, A. Growth inhibition by cholera toxin of human lung carcinoma cell lines: correlation with GM1 ganglioside expression. Cancer Res., 52: 3340-3346, 1992.
35. Jonge, R. R., Garrigue-Antar, L., Vellucci, V. F., and Reiss, M. Frequent inactivation of the transforming growth factor beta type II receptor in small-cell lung carcinoma cells. Oncol. Res., 9: 89-98, 1997.